FDA Approves New Treatment for Late-Stage Melanoma
Melanoma patients lived longer with treatment The U.S. Food and Drug Administration today approved Yervoy (ipilimumab) to treat patients with late-stage (metastatic) melanoma, the most dangerous type of skin cancer. Melanoma is the leading cause of death from skin disease. An estimated 68,130 new cases of melanoma were diagnosed in the United States during 2010 [...]
Mar 26 2011 | Posted in Cancer Research | Read More »
